Navigation Links
Clinical trial volunteers mostly indifferent -- but not blind to -- researchers' financial conflicts
Date:4/4/2008

the recruits, almost all white, were well educated and had middle to high income levels. They were located in all regions of the United States.

Most of the respondents indicated that the financial disclosure was less important to their decision about participating than such factors as potential risks and benefits, and the purpose of the research.

In the computerized experiment, the investigators electronically sent each patient a description of a hypothetical clinical trial to test a drug that might treat their particular condition. The recipients were grouped by the severity of their illnesses.

Tagged onto the description of the clinical trial was one of five different financial disclosures: a generic one suggesting that the study leader might benefit financially from the study; one saying that the study leader would be reimbursed only for expenses pertaining to the trial; one indicating that the study leader receives extra money from the drug company for activities such as consulting or speaking; one indicating that the study leader holds stock in the drug company; or one indicating that the researchers institution holds stock in the drug company.

The generic disclosure, for example, said that the researchers institution had reviewed Dr. Smiths financial conflict and concluded that it would not affect the safety or outcome of the clinical trial, but offered to provide more information if the participant wanted it.

The equity disclosure said that the amount of financial investment of Dr. Smith might be affected by the outcome of the clinical trial and that in effect, Dr. Smith could gain or lose money depending on what the trial concluded.

The patients were asked to read the material then respond to a computer-based survey indicating their willingness to participate in the trial, the importance of the financial disclosure in making their decision, their trust in researchers, their level of surprise about t
'/>"/>

Contact: Christen Brownlee
cbrownlee@jhmi.edu
410-955-7832
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Clinical trial will test new HIV/AIDS vaccine
2. Knowing doctors financial interests doesnt deter clinical trial participants
3. Report Claims Clinical Trials Miss Many Populations
4. PPD Names Mike Wilkinson Executive Vice President of Global Clinical Development
5. Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
6. Patients Do Better at Hospitals With Clinical Trials
7. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
8. Haymarket Adds Two Cancer Journals to Its Family of Clinical Publications
9. Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments
10. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
11. SearchMedica Offers Medical Professionals Six New Specialized Clinical Web Searches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... The 6th Annual Survivor in the City, ... added yet another accolade to its cadre of widespread support—an official letter of support ... help of the medical community and the University of Illinois at Chicago’s Department of ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, ... fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch ... CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected ...
(Date:8/28/2015)... ... August 28, 2015 , ... Drugs and ... James Strawbridge, gives a new approach on solutions in his new book ":Unraveling ... employer and employees getting together for meaningful group meetings. "This would educate the ...
(Date:8/28/2015)... ... 28, 2015 , ... CARF International announced that West Ridge ... treatment and intensive family based services. , By pursuing and achieving accreditation, West ... of excellence. As a nonprofit charity for more than 50 years, West Ridge ...
(Date:8/28/2015)... Rochester, NY (PRWEB) , ... August 28, 2015 , ... ... injectable, Kybella™. It is the first and only nonsurgical product approved by the ... Dr. Vito Quatela and Dr. William Koenig are among ...
Breaking Medicine News(10 mins):Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3
... News) -- A growing number of Americans are getting advice ... rather than friends, a new survey indicates. About ... media such as Facebook and Twitter, a substantial increase from ... who sought information from friends fell from 63 percent in ...
... Moffitt Cancer Center in Tampa, Fla., have discovered that ... roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens ... The study was published in a recent issue ... identified oconogene, a gene linked to cancer," said study ...
... BOSTON (2-8-12) Observing that certain cancer cells may ... that this capability promotes rapid tumor growth. Now computer ... Muhammad Zaman and collaborators at the University of Texas ... model of healthy and cancer cells that they,ve created ...
... In a study to be presented today at the ... , in Dallas, Texas, researchers will report findings that ... section appear to know little about the risks and ... trial of labor to attempt a vaginal delivery, and ...
... TAMPA, Fla. and ORLANDO, Fla. Moffitt Cancer ... have announced they will collaborate on the creation ... Florida). The partnership will conduct collaborative research to ... areas of cancer and metabolic diseases, including obesity, ...
... supports an association between atypical fractures of the femur a ... and the use of bisphosphonates, drugs proven to enhance bone ... risk for suffering an atypical femur fracture while taking bisphosphonates ... after six years of treatment research presented today at ...
Cached Medicine News:Health News:More Patients Seek Plastic Surgery Advice From Facebook, Twitter 2Health News:Researchers find important 'target' playing role in tobacco-related lung cancers 2Health News:Boston University research suggests new pathways for cancer progression 2Health News:Study finds pregnant women with prior cesarean choose the delivery method preferred by their doctor 2Health News:Moffitt, Sanford-Burnham and Florida Hospital create Personalized Medicine Partnership of Florida 2Health News:Moffitt, Sanford-Burnham and Florida Hospital create Personalized Medicine Partnership of Florida 3Health News:Halting bone-building osteoporosis drug use cuts risk for additional atypical femur fracture in half 2
(Date:8/28/2015)... SEOUL, South Korea , Aug. 28, 2015 /PRNewswire/ ... Chungbuk National University and Dr. Ra from Biostar ... , Confirmed 30% increase of lifespan through multiple ... cognitive function, physical vitality, and life expectancy found ... Researchers in Korea have determined the possibility that adult ...
(Date:8/27/2015)... , Aug. 27, 2015  The Academy of ... and Drug Administration,s (FDA,s) draft guidance and proposed ... and biosimilars, to bear a nonproprietary name with ... been seeking a decision from the FDA on ... health care stakeholders urging the agency to use ...
(Date:8/27/2015)... -- According to a new market research report "Medical ... Bariatric ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, Reusable), End ... the Medical Lifting Sling Market is poised to reach USD 706.0 ... CAGR of 11.4 % from 2015 to 2020. ... T ables and 65 F ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
... 2011 Hurricane Irene came rushing up the East Coast as ... the United States, many states in the Northeast began to worry. ... to hurricanes. Coastal towns from New Jersey all the way up ... York City was one that took steps that had not been ...
... DIEGO, Aug. 30, 2011 ADVENTRX Pharmaceuticals, Inc. (NYSE ... on its planned meetings with the U.S. Food and ... Exelbine (vinorelbine injectable emulsion) Type ... is to discuss the complete response letter regarding the ...
Cached Medicine Technology:Hospitals Evacuated in Preparation for Hurricane Irene with Aid of Pulse Oximeter 2ADVENTRX Provides Update on All Three Pipeline Products 2ADVENTRX Provides Update on All Three Pipeline Products 3ADVENTRX Provides Update on All Three Pipeline Products 4
Denman brown nucleus cracker with 30 angled shafts, tip to angle length 14.5 mm. Standard cross action handle. 1.1 mm x 1.2 mm paddle style tips....
Ernest nucleus cracker extra delicate cross-action serrated paddle shaped jaws for cracking the nucleus through a 2.5 mm incision....
Epilation forceps straight ends size 3.5"....
Removal Forceps, very fine pointed tips, with textured jaws, ideal for grasping wet sutures....
Medicine Products: